MacroGenics Earnings Estimate

By analyzing MacroGenics' earnings estimates, investors can diagnose different trends across MacroGenics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for MacroGenics is based on EPS before non-recurring items and includes expenses related to employee stock options. MacroGenics is projected to generate -0.655 in earnings per share on the 31st of March 2026. MacroGenics earnings estimates show analyst consensus about projected MacroGenics EPS (Earning Per Share). It derives the highest and the lowest estimates based on MacroGenics' historical volatility. Many public companies, such as MacroGenics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing MacroGenics' earnings estimates, investors can diagnose different trends across MacroGenics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to drop to about 92.4 M in 2026. Pretax Profit Margin is likely to drop to -0.54 in 2026Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MacroGenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.